Search
for

    Glossary Maraviroc

    medication that blocks HIV from entering white blood cells

    Maraviroc is a medication primarily used to treat HIV infection. It works by blocking the CCR5 receptor on white blood cells, which prevents the virus from entering and infecting these cells. This helps to reduce the viral load in the body and improve immune function.

    Sort by

    Research 13

    1. 219 STAT5 activation in the dermal papilla is important for hair follicle growth phase induction, hair follicle regeneration and wound healing Journal of Investigative Dermatology · 2016 · 1 citations
    2. 264 CCR5 blockade shows prevention of alopecia areata development as well as improvement of alopecia areata 2017
    3. 266 Glycogen metabolism and Cori cycle in human hair follicles 2017
    4. Proceedings of the Ninth World Congress for Hair Research (2015) Journal of Investigative Dermatology Symposium Proceedings · 2017
    5. 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata Journal of Investigative Dermatology · 2016
    6. 217 The adenosine-generating ecto-enzyme CD73 regulates human hair growth Journal of Investigative Dermatology · 2016
    7. A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation Journal of Pharmaceutical Sciences · 2020
    8. PCSK9: From Nature’s Loss to Patient’s Gain Circulation · 2024
    9. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion Viruses · 2022 · 52 citations
    10. Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development Frontiers in Pharmacology · 2022 · 17 citations
    11. A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle Frontiers in Immunology · 2025 · 1 citations
    12. Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy Pharmaceuticals · 2025
    13. Cytokine profiles associated with persisting symptoms of post-acute sequelae of COVID-19 The Korean Journal of Internal Medicine · 2025